A patent cliff is approaching for Merck’s flagship blockbuster Keytruda, which could open the door for biosimilars. However, these biosimilars may encounter significant challenges in gaining widespread market traction. Factors such as market competition, pricing strategies, and regulatory hurdles could impact their adoption.
This situation may create opportunities for manufacturers and suppliers to strategize on how to position their products effectively in a competitive landscape. Buyers may also need to consider the implications of these developments on pricing and availability of treatments.
Source: biopharmadive.com · Image: Naitō Museum of Pharmaceutical Science and Industry 20210529 30 by 先従隗始, CC0, via Wikimedia Commons
Planning your supply chain?
The API & FDF Intelligence database shows where manufacturers are located, which certificates they hold, and which markets are overheated.
With direct contacts for every supplier and holder, you can move from weeks of outreach to decisions made in hours.
Use the database as your supply chain compass →
Use the database as your supply chain compass →
